Is recombinant tissue plasminogen activator treatment a safe choice in very and extremely preterm infants with intracardiac thrombosis?

Arch Dis Child. 2022 May 10:archdischild-2022-323789. doi: 10.1136/archdischild-2022-323789. Online ahead of print.

Authors

Martina Ciarcià¹, Iuri Corsini², Francesca Miselli¹, Michele Luzzati¹, Caterina Coviello³, Valentina Leonardi³, Simone Pratesi³, Carlo Dani¹

Affiliations

¹ Department of Neurosciences, Psychology, Drug Research and Child Health, Careggi University Hospital, Firenze, Italy.
² Division of Neonatology, Careggi University Hospital of Florence, Firenze, Italy corsiniiuri@gmail.com.
³ Division of Neonatology, Careggi University Hospital of Florence, Firenze, Italy.

PMID: 35537825
DOI: 10.1136/archdischild-2022-323789

No abstract available

Keywords: Cardiology; Intensive Care Units, Neonatal; Neonatology.